Type 1 Papillary Renal Cell Carcinoma Recruiting Phase 2 Trials for Cabozantinib (DB08875)

Also known as: Papillary Renal Cell Carcinoma Type 1

IndicationStatusPhase
DBCOND0029157 (Type 1 Papillary Renal Cell Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03685448ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)Treatment